Pleckstrin inhibitors constitute a category of chemical compounds designed to target and inhibit the activity of the pleckstrin protein or pleckstrin homology (PH) domains found in various signaling proteins. Pleckstrin is a family of intracellular proteins involved in signal transduction pathways, particularly those associated with membrane receptor activation and intracellular membrane trafficking. PH domains, on the other hand, are small protein motifs often found in signaling proteins, and they are known for their ability to bind to specific phospholipids in cellular membranes. Inhibitors of pleckstrin or its PH domains are primarily developed for research purposes, serving as indispensable tools for molecular biologists and cell biologists to investigate the intricate mechanisms of cellular signaling, membrane dynamics, and protein-membrane interactions.
Typically, pleckstrin inhibitors are composed of small molecules or chemical compounds that are designed to interfere with the pleckstrin protein or PH domains' normal function. By inhibiting pleckstrin or its PH domains, these compounds can disrupt the signaling pathways or membrane interactions in which these proteins are involved. Researchers employ pleckstrin inhibitors in laboratory settings to manipulate specific aspects of cellular signaling cascades and membrane dynamics, allowing for a deeper understanding of how cells communicate and respond to external cues. These inhibitors serve as invaluable tools for studying the complex and tightly regulated processes that govern cell signaling, membrane trafficking, and membrane-protein interactions. While pleckstrin inhibitors may have potential applications beyond basic research, their primary purpose is to aid scientists in elucidating the molecular intricacies of pleckstrin-mediated cellular functions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Binds to DNA at transcription initiation complexes, potentially reducing mRNA transcription, including that of pleckstrin. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Blocks eukaryotic protein synthesis by inhibiting the translocation step, possibly reducing pleckstrin protein levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR signaling, which could lead to a decrease in protein synthesis, affecting pleckstrin levels. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
As a PI3K inhibitor, it could disrupt signaling pathways that regulate pleckstrin expression. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Inhibits transcription by RNA polymerase I, II, and III, potentially reducing pleckstrin mRNA levels. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $65.00 $99.00 $140.00 | 85 | |
Crosslinks DNA, potentially inhibiting transcription and thereby reducing pleckstrin expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor, could lead to altered cellular signaling and affect pleckstrin expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor, can modify chromatin and affect gene expression, including pleckstrin. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, it could demethylate DNA and alter gene expression, including of pleckstrin. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
May affect autophagy and endosomal trafficking pathways, potentially influencing pleckstrin expression. | ||||||